Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms19030905 http://scihub22266oqcxt.onion/10.3390/ijms19030905 C5877766!5877766 !29562695     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29562695 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Int+J+Mol+Sci 2018 ; 19 (3 ): ? Nephropedia Template TP {{tp|p=29562695 |t=2018. Galectins as Molecular Targets for Therapeutic Intervention |pdf=|usr=}}{{29562695 }} gab.com Text Galectins as Molecular Targets for Therapeutic Intervention JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=29562695 #FOAvip Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting ?-galactoside epitopes. Because of their significant involvement in various biological functions and pathologies, galectins have become a focus of therapeutic discovery for clinical intervention against cancer, among other pathological disorders. In this review, we focus on understanding galectin structure-function relationships, their mechanisms of action on the molecular level, and targeting them for therapeutic intervention against cancer. Twit Text FOAVip Galectins as Molecular Targets for Therapeutic Intervention ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=29562695 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29562695 #FOAvip English Wikipedia <ref>{{Cite pmid|29562695 }}</ref> Galectins as Molecular Targets for Therapeutic Intervention #MMPMID29562695 Dings RPM ; Miller MC ; Griffin RJ ; Mayo KH Int J Mol Sci 2018[Mar]; 19 (3 ): ? PMID29562695 show ga Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting ?-galactoside epitopes. Because of their significant involvement in various biological functions and pathologies, galectins have become a focus of therapeutic discovery for clinical intervention against cancer, among other pathological disorders. In this review, we focus on understanding galectin structure-function relationships, their mechanisms of action on the molecular level, and targeting them for therapeutic intervention against cancer. |*Molecular Targeted Therapy [MESH] |Animals [MESH] |Carbohydrates/chemistry [MESH] |Drug Therapy, Combination [MESH] |Galectins/chemistry/*metabolism [MESH]Galectins as Molecular Targets for Therapeutic Intervention (epmc).pdf DeepDyve Pubget Overpricing